These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1140 related articles for article (PubMed ID: 19672093)

  • 41. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
    Ceuppens JL; Bullens D; Kleinjans H; van der Werf J;
    Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Allergen-specific immunotherapy with recombinant grass pollen allergens.
    Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
    J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
    Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular characterization of Bip 1, a monoclonal antibody that modulates IgE binding to birch pollen allergen, Bet v 1.
    Laffer S; Vangelista L; Steinberger P; Kraft D; Pastore A; Valenta R
    J Immunol; 1996 Dec; 157(11):4953-62. PubMed ID: 8943401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgE and allergen-specific immunotherapy-induced IgG
    Groh N; von Loetzen CS; Subbarayal B; Möbs C; Vogel L; Hoffmann A; Fötisch K; Koutsouridou A; Randow S; Völker E; Seutter von Loetzen A; Rösch P; Vieths S; Pfützner W; Bohle B; Schiller D
    Clin Exp Allergy; 2017 May; 47(5):693-703. PubMed ID: 27770477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4).
    Mari A; Wallner M; Ferreira F
    Clin Exp Allergy; 2003 Oct; 33(10):1419-28. PubMed ID: 14519150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allergen hybrids - next generation vaccines for Fagales pollen immunotherapy.
    Pichler U; Hauser M; Hofer H; Himly M; Hoflehner E; Steiner M; Mutschlechner S; Hufnagl K; Ebner C; Mari A; Briza P; Bohle B; Wiedermann U; Ferreira F; Wallner M
    Clin Exp Allergy; 2014 Mar; 44(3):438-49. PubMed ID: 24330218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How far can we simplify in vitro diagnostics for Fagales tree pollen allergy? A study with three whole pollen extracts and purified natural and recombinant allergens.
    Van Ree R; Van Leeuwen WA; Akkerdaas JH; Aalberse RC
    Clin Exp Allergy; 1999 Jun; 29(6):848-55. PubMed ID: 10336603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation.
    Vrtala S; Ball T; Spitzauer S; Pandjaitan B; Suphioglu C; Knox B; Sperr WR; Valent P; Kraft D; Valenta R
    J Immunol; 1998 Jun; 160(12):6137-44. PubMed ID: 9637531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The allergen profile of beech and oak pollen.
    Egger C; Focke M; Bircher AJ; Scherer K; Mothes-Luksch N; Horak F; Valenta R
    Clin Exp Allergy; 2008 Oct; 38(10):1688-96. PubMed ID: 18754759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel approach for investigation of specific and cross-reactive IgE epitopes on Bet v 1 and homologous food allergens in individual patients.
    Mittag D; Batori V; Neudecker P; Wiche R; Friis EP; Ballmer-Weber BK; Vieths S; Roggen EL
    Mol Immunol; 2006 Feb; 43(3):268-78. PubMed ID: 16199263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasal allergen-neutralizing IgG
    Shamji MH; Kappen J; Abubakar-Waziri H; Zhang J; Steveling E; Watchman S; Kouser L; Eifan A; Switzer A; Varricchi G; Marone G; Couto-Francisco NC; Calderon M; Durham SR
    J Allergy Clin Immunol; 2019 Mar; 143(3):1067-1076. PubMed ID: 30445057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
    Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
    J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen.
    Park HS; Nahm DH; Kim HY; Suh YJ; Cho JW; Kim SS; Lee SK; Jung KS
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):444-8. PubMed ID: 11345290
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A sensitive assay for the detection of IgE bound to the major birch pollen allergen, Bet v 1, in the form of immune complexes.
    Pree I; Reisinger J; Bohle B; Frantal S; Valenta R; Niederberger V
    J Immunol Methods; 2009 Jun; 345(1-2):100-5. PubMed ID: 19376122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe.
    Ghunaim N; Grönlund H; Kronqvist M; Grönneberg R; Söderström L; Ahlstedt S; van Hage-Hamsten M
    Allergy; 2005 Feb; 60(2):185-91. PubMed ID: 15647039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.